Learn about the latest advances in diabetes and other endocrine disorders from the expert of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai. Our physician-scientists are on the leading edge of diabetes discoveries that have immediate impact on our patients. Andrew Stewart, MD, focuses his research on innovative therapies to regenerate insulin-producing pancreatic beta cells. Carol Levy, MD, directed the first clinical trials for the artificial pancreas. Division Chief Andrea Dunaif, MD, is a leading researcher in genes for polycystic ovary syndrome, a major cause of diabetes in women. We also have multidisciplinary centers of excellence in adrenal, pituitary, and thyroid disorders, as well as in weight management.
The Diabetes & Endocrinology Department at the Mount Sinai Hospital is proud to be ranked No. 14 in the nation by U.S. News & World Report Best Hospitals for 2022-23.
Learn about the latest advances in diabetes and other endocrine disorders from the expert of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai. Our physician-scientists are on the leading edge of diabetes discoveries that have immediate impact on our patients. Andrew Stewart, MD, focuses his research on innovative therapies to regenerate insulin-producing pancreatic beta cells. Carol Levy, MD, directed the first clinical trials for the artificial pancreas. Division Chief Andrea Dunaif, MD, is a leading researcher in genes for polycystic ovary syndrome, a major cause of diabetes in women. We also have multidisciplinary centers of excellence in adrenal, pituitary, and thyroid disorders, as well as in weight management.
The Diabetes & Endocrinology Department at the Mount Sinai Hospital is proud to be ranked No. 14 in the nation by U.S. News & World Report Best Hospitals for 2022-23.
Latest Content |view more
Gaining Genomic Insights Into the Mechanisms and Classification of PCOS
Andrea Dunaif, MD, Chief of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, a world leader in the study of disorders of metabolism and reproduction, is heading ...
In a study with the potential to change current practice, a Mount Sinai research team found the risk of blood clots to be minimal, and that patients can safely remain on critical estrogen therapy during their surgery.
Medicine Multispecialty at Mount Sinai Morningside Is Advancing Collaborative Care
A new ambulatory practice, Medicine Multispecialty at Mount Sinai Morningside, was launched in February 2021, dedicated to providing integrated, team-based care that meets the complex needs of patients, especially those with chronic disease.
Mount Sinai Surgeons Innovate With Scar-Free Thyroidectomy Technique
Two Mount Sinai endocrine surgeons were among the first in the United States to use a novel minimally invasive scar-free thyroidectomy approach, with continuing successful outcomes in more than 100 patients thus far.
Promising Results in Trial of Artificial Pancreas System for Pregnant Women With Type 1 Diabetes
Mount Sinai is one of three U.S. sites participating in a clinical trial of an experimental “artificial pancreas” system customized for the stringent glucose targets recommended for optimal maternal and fetal outcomes of pregnancies complicated by diabetes.
Revised Approach to Managing “Pheo” Adrenal Tumors Is Developed During COVID-19 Pandemic
When the COVID-19 crisis forced New York hospitals to delay all non-urgent surgeries, clinicians at Mount Sinai’s Adrenal Center were able to safely manage three patients with newly diagnosed pheochromocytomas for longer than the recommended ...
Healthy Lifestyle Clinic Offers Weight Management Program for Children and Teens
A Q&A with the head of the Healthy Lifestyle Clinic, a weight management program for children and teens with obesity and obesity-related health complications.
Institute Is Expanding the Understanding of Diabetes, Obesity, and Metabolism
The Institute has expanded significantly in the last 10 years as its laboratories investigate the the pathophysiology of both type 1 and type 2 diabetes, and develop better therapeutic and prevention strategies for those who suffer from ...
Beta Cell Proliferation Research to Investigate Harmine in Phase 1 Trial
Mount Sinai researchers are developing a novel two-drug approach to treating diabetes that enables the regeneration of insulin-producing pancreatic beta cells.
Newly Merged Endocrinology Fellowship Program Is the Nation’s Largest and Most Diverse
The merger of Endocrinology fellowships at Mount Sinai into a system-wide program has created not only the largest training effort of its type in the country, but one offering participants an unmatched diversity of clinical and research ...
Message From the Chief, Andrea Dunaif, MD
The Division of Endocrinology, Diabetes and Bone Disease had a welcome return to more normal operations in 2021.
Endocrinology, Diabetes and Bone Disease Specialty Report 2022
The Division of Endocrinology, Diabetes and Bone Disease had a welcome return to more normal operations in 2021. Our superb faculty continue to be at the forefront of developing innovative approaches to provide optimal clinical care for ...
Endocrinology, Diabetes and Bone Disease Specialty Report 2021
It goes without saying that 2020 was an extraordinary year. Mount Sinai was at the epicenter of the pandemic in its early days.
New Study Identifies Better Treatment Option for Common Complication of Dialysis
A Mount Sinai study has identified a better treatment option to treat arteriovenous fistulas, a common complication of hemodialysis
Retinal Imaging and Management of Diabetic Retinopathy
Gareth Lema, MD, PhD, discusses diagnostic imaging technology and treatment for diabetic retinopathy in this Grand Rounds presentation
Euglycemic Diabetic Ketoacidosis in the Modern Era
David W. Lam, MD, discusses euglycemic diabetic ketoacidosis in this Grand Rounds presentation
Tamar Reisman, MD, discusses the process of breast development and lactation, endocrine-mediated processes, and a case in which functional lactation was induced in a transgender patient